In-silico Drug Design and in-silico screening

In-silico drug design can take part much in all stages of drug development from the preclinical discovery stage to late stage clinical development.

During the process of selection of novel drug candidates, many essential steps are taken to eliminate such compounds that have side effects and also show interaction with other drugs. In-silico drug designing softwares show an important role to design progressive proteins or drugs in biotechnology or the pharmaceutical field. 

  • Structural Biology
  • Molecular Docking
  • Virtual Screening Methods
  • Computation approaches for fragment based Drug Discovery
  • Intellectual property issues arising from in silico Discovery
  • Enzyme Inhibitors

Related Conference of In-silico Drug Design and in-silico screening

November 09-11, 2017

4th European Biopharma Congress

Vienna, Austria
August 20-22, 2018

9th Asian Biologics and Biosimilars Congress

Tokyo, Japan

In-silico Drug Design and in-silico screening Conference Speakers

Recommended Sessions

Related Journals

Are you interested in